Thomas Kelly
CEO & Founder @ Heidi Health
Thomas Kelly is a pre-seed investor at Heidi Health focused on FinTech and Financial Services.
- Total investments:
- 1
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Thomas Kelly invests in
Stages Thomas Kelly invests in
Countries Thomas Kelly invests in
Investment Focus
Industry
- FinTech 1 (100%)
- Financial Services 1 (100%)
- Artificial Intelligence 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Marloo
|
Marloo is an AI-assistant that empowers financial advisers to focus on building client relationships, instead of paperwork. | $2.7M / Pre-Seed / Sep 08, 2025 |
Co-Investors
About Heidi Health
Heidi Health develops an ambient AI medical scribe platform that automates clinical documentation and related tasks. It listens to patient-clinician conversations, transcribes key highlights, and then produces structured notes, referral letters, patient summaries, billing codes, and other downstream documents. The system supports customizabletemplates, allows editing during sessions, and integrates with various EHR systems while offering compliance with privacy and security standards. Clinicians in multiple specialties and care settings use Heidi to reduce administrative burden, improve focus on patient care, and streamline workflows.
Heidi Health Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Nancy Cibotti
US Chief Medical Information Officer
|
|||
Nell Hardie
Head of People
|
|||
Paul Williamson
Chief Revenue Officer
|
|||
Simon Kos
Chief Medical Officer
|
|||
|
Thomas Kelly
CEO & Founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Thomas Kelly invest in?
Thomas Kelly invests primarily in FinTech, Financial Services and Artificial Intelligence startups, most often at Pre-Seed stage. Most of the 1 investments tracked by Shizune back companies in New Zealand. The Investment Focus section breaks down every industry, stage and country in the portfolio.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
